Tricida

$7.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Tricida and other stocks, options, and ETFs commission-free!

About TCDA

Tricida, Inc. Common Stock, also called Tricida, is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA. The listed name for TCDA is Tricida, Inc. Common Stock.

CEO

Gerrit Klaerner

Employees

119

Headquarters

South San Francisco, California

Founded

2013

Market Cap

358.82M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

503.14K

High Today

$7.20

Low Today

$6.91

Open Price

$7.10

Volume

313.72K

52 Week High

$39.02

52 Week Low

$3.74

Collections

TCDA Earnings

-$1.46

-$0.97

-$0.49

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 25, After Hours